These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37858709)

  • 1. The Financial Burden of Aspirin versus Oral Factor Xa Inhibitors for Thromboprophylaxis Following Total Knee Arthroplasty.
    Bergstein VE; Taylor WL; Weinblatt AI; Lesser LC; Long WJ
    J Arthroplasty; 2024 Apr; 39(4):935-940. PubMed ID: 37858709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin Thromboprophylaxis Following Primary Total Knee Arthroplasty Is Associated With a Lower Rate of Early Prosthetic Joint Infection Compared With Other Agents.
    Anil U; Kirschner N; Teo GM; Lygrisse KA; Sicat CS; Schwarzkopf R; Aggarwal VK; Long WJ
    J Arthroplasty; 2023 Jun; 38(6S):S345-S349. PubMed ID: 36828050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
    Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
    PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.
    Sun G; Wu J; Wang Q; Liang Q; Jia J; Cheng K; Sun G; Wang Z
    J Arthroplasty; 2019 Apr; 34(4):789-800.e6. PubMed ID: 30685261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous Thromboembolism Prophylaxis After TKA: Aspirin, Warfarin, Enoxaparin, or Factor Xa Inhibitors?
    Bala A; Huddleston JI; Goodman SB; Maloney WJ; Amanatullah DF
    Clin Orthop Relat Res; 2017 Sep; 475(9):2205-2213. PubMed ID: 28569372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboprophylaxis after total hip arthroplasty: aspirin, warfarin, enoxaparin, or factor Xa inhibitors?
    Bala A; Murasko MJ; Burk DR; Huddleston JI; Goodman SB; Maloney WJ; Amanatullah DF
    Hip Int; 2020 Sep; 30(5):564-571. PubMed ID: 30990095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 90-Day Adverse Events Associated With Aspirin and Potent Anticoagulation Use for Venous Thromboembolism Prophylaxis: A Cohort Study of 72,288 Total Knee and 35,142 Total Hip Arthroplasty Patients.
    Singh G; Prentice HA; Winston BA; Kroger EW
    J Arthroplasty; 2023 Aug; 38(8):1602-1612.e1. PubMed ID: 36805118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty.
    Cafri G; Paxton EW; Chen Y; Cheetham CT; Gould MK; Sluggett J; Bini SA; Khatod M
    J Arthroplasty; 2017 Nov; 32(11):3524-3528.e1. PubMed ID: 28634095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Aspirin as Effective as the Newer Direct Oral Anticoagulants for Venous Thromboembolism Prophylaxis After Total Hip and Knee Arthroplasty? An Analysis From the National Joint Registry for England, Wales, Northern Ireland, and the Isle of Man.
    Matharu GS; Garriga C; Whitehouse MR; Rangan A; Judge A
    J Arthroplasty; 2020 Sep; 35(9):2631-2639.e6. PubMed ID: 32532481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty.
    Wilson DG; Poole WE; Chauhan SK; Rogers BA
    Bone Joint J; 2016 Aug; 98-B(8):1056-61. PubMed ID: 27482017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral direct factor Xa inhibitor versus enoxaparin for thromboprophylaxis after hip or knee arthroplasty: Systemic review, traditional meta-analysis, dose-response meta-analysis and network meta-analysis.
    Feng W; Wu K; Liu Z; Kong G; Deng Z; Chen S; Wu Y; Chen M; Liu S; Wang H
    Thromb Res; 2015 Dec; 136(6):1133-44. PubMed ID: 26498222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing Australian orthopaedic surgeons' reported use of thromboprophylaxis following arthroplasty in 2012 and 2017.
    Mirkazemi C; Bereznicki LR; Peterson GM
    BMC Musculoskelet Disord; 2019 Feb; 20(1):57. PubMed ID: 30736774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review.
    Adam SS; McDuffie JR; Lachiewicz PF; Ortel TL; Williams JW
    Ann Intern Med; 2013 Aug; 159(4):275-84. PubMed ID: 24026260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of aspirin against rivaroxaban for venous thromboembolism prophylaxis after hip or knee arthroplasty: A meta-analysis.
    Xu J; Kanagaratnam A; Cao JY; Chaggar GS; Bruce W
    J Orthop Surg (Hong Kong); 2020; 28(1):2309499019896024. PubMed ID: 31908175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty.
    Schousboe JT; Brown GA
    J Bone Joint Surg Am; 2013 Jul; 95(14):1256-64. PubMed ID: 23864173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin as Thromboprophylaxis in Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis.
    An VV; Phan K; Levy YD; Bruce WJ
    J Arthroplasty; 2016 Nov; 31(11):2608-2616. PubMed ID: 27178011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Effectiveness of Aspirin as Multimodal Thromboprophylaxis in Primary Total Hip and Knee Arthroplasty: A Review of 6078 Cases.
    Ghosh A; Best AJ; Rudge SJ; Chatterji U
    J Arthroplasty; 2019 Jul; 34(7):1359-1363. PubMed ID: 30982759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-Dose Aspirin for Venous Thromboembolism Prophylaxis is Associated With Lower Rates of Periprosthetic Joint Infection After Total Joint Arthroplasty.
    Najafi F; Kendal JK; Peterson NV; Ciesielka KA; Restrepo C; Parvizi J; Bernthal NM
    J Arthroplasty; 2022 Dec; 37(12):2444-2448.e1. PubMed ID: 35843380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Incidence of Bleeding and Wound Complications With Factor-Xa Inhibitors After Total Joint Arthroplasty.
    Garfinkel JH; Gladnick BP; Roland N; Romness DW
    J Arthroplasty; 2018 Feb; 33(2):533-536. PubMed ID: 28947374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous Thromboembolism in Total Hip and Total Knee Arthroplasty.
    Simon SJ; Patell R; Zwicker JI; Kazi DS; Hollenbeck BL
    JAMA Netw Open; 2023 Dec; 6(12):e2345883. PubMed ID: 38039005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.